MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s12072-020-10105-2

Медицинская библиотека · Hepatology international · 2020

HCC risk post-SVR with DAAs in East Asians: findings from the REAL-C cohort.

Tanaka Yasuhito, Ogawa Eiichi, Huang Chung-Feng, Toyoda Hidenori, Jun Dae Won, Tseng Cheng-Hao, Hsu Yao-Chun, Enomoto Masaru, Takahashi Hirokazu, Furusyo Norihiro, Yeh Ming-Lun, Iio Etsuko, Yasuda Satoshi, Lam Carla Pui-Mei, Lee Dong Hyun, Haga Hiroaki, Yoon Eileen L, Ahn Sang Bong, Wong Grace, Nakamuta Makoto, Nomura Hideyuki, Tsai Pei-Chien, Jung Jang Han, Song Do Seon, Dang Hansen, Maeda Mayumi, Henry Linda, Cheung Ramsey, Yuen Man-Fung, Ueno Yoshiyuki, Eguchi Yuichiro, Tamori Akihiro, Yu Ming-Lung, Hayashi Jun, Nguyen Mindie H, REAL-C Investigators

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Despite HCV cure, patients remain at risk for HCC, but risk factor data for HCC following SVR are limited for Asian patients.

METHODS

To address this gap, we analyzed 5814 patients (5646 SVR, 168 non-SVR) from the Real-World Evidence from the Asia Liver Consortium for HCV (REAL-C) who did not have HCC or a history of HCC at baseline (pre-DAA treatment) and did not develop HCC within 6 months of baseline. To assess the effect of SVR on HCC incidence, we used 1:4 propensity score matching [(PSM), age, sex, baseline cirrhosis, and baseline AFP] to balance the SVR and non-SVR groups.

RESULTS

In the PSM cohort (160 non-SVR and 612 SVR), the HCC incidence rate per 100 person years was higher in the non-SVR compared to the SVR group (5.26 vs. 1.94, p < 0.001). Achieving SVR was independently associated with decreased HCC risk (adjusted HR [aHR]: 0.41, p = 0.002). Next, we stratified the SVR cohort of 5646 patients to cirrhotic and noncirrhotic subgroups. Among cirrhotic SVR patients, aged ≥ 60, having an albumin bilirubin grade (ALBI) of 2 or 3 (aHR: 2.5, p < 0.001), and baseline AFP ≥ 10 ng/mL (aHR: 1.6, p = 0.001) were associated with higher HCC risk, while among the non-cirrhotic SVR group, only baseline AFP ≥ 10 ng/mL was significant (aHR: 4.26, p = 0.005).

CONCLUSIONS

Achieving SVR decreases HCC risk; however, among East Asians, patients with elevated pretreatment AFP remained at risk. Pretreatment AFP, an easily obtained serum marker, may provide both prognostic and surveillance value for HCC in East Asian patients who obtained SVR.

Для цитирования: Tanaka Yasuhito, Ogawa Eiichi, Huang Chung-Feng, Toyoda Hidenori, Jun Dae Won, Tseng Cheng-Hao, Hsu Yao-Chun, Enomoto Masaru, Takahashi Hirokazu, Furusyo Norihiro, Yeh Ming-Lun, Iio Etsuko, Yasuda Satoshi, Lam Carla Pui-Mei, Lee Dong Hyun, Haga Hiroaki, Yoon Eileen L, Ahn Sang Bong, Wong Grace, Nakamuta Makoto, Nomura Hideyuki, Tsai Pei-Chien, Jung Jang Han, Song Do Seon, Dang Hansen, Maeda Mayumi, Henry Linda, Cheung Ramsey, Yuen Man-Fung, Ueno Yoshiyuki, Eguchi Yuichiro, Tamori Akihiro, Yu Ming-Lung, Hayashi Jun, Nguyen Mindie H, REAL-C Investigators. HCC risk post-SVR with DAAs in East Asians: findings from the REAL-C cohort.. Hepatology international. 2020. DOI: 10.1007/s12072-020-10105-2.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.